Related references
Note: Only part of the references are listed.ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models
Tiziana Vaisitti et al.
BLOOD (2021)
The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
Kerstin Menck et al.
CELLS (2021)
WNT inhibition creates a BRCA-like state in Wnt-addicted cancer
Amanpreet Kaur et al.
EMBO MOLECULAR MEDICINE (2021)
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours
Jordi Rodon et al.
BRITISH JOURNAL OF CANCER (2021)
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
Silvia Schmidtova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer
S. Lindsey Davis et al.
INVESTIGATIONAL NEW DRUGS (2020)
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma
Menggui Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Allosteric inhibitor of β-catenin selectively targets oncogenic Wnt signaling in colon cancer
Anton Cheltsov et al.
SCIENTIFIC REPORTS (2020)
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
Whitney N. Goldsberry et al.
CANCERS (2020)
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
Jennifer R. Diamond et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples
Shradha Mukherjee
SCIENTIFIC REPORTS (2020)
Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma
Eun-Jin Yun et al.
CELL DEATH & DISEASE (2020)
Targeting the Wnt/β-catenin signaling pathway in cancer
Ya Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells
Nishani Rajakulendran et al.
GENES & DEVELOPMENT (2019)
Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells
Amin Kamrani et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice
Hiroyasu Okazaki et al.
EXPERIMENTAL LUNG RESEARCH (2019)
Wnt pathway markers in molecular subgroups of glioblastoma
Marton Tompa et al.
BRAIN RESEARCH (2019)
A phase 1b dose escalation study of ipafricept (OMP-54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Kathleen N. Moore et al.
GYNECOLOGIC ONCOLOGY (2019)
The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies
Larisa Ryskalin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways
Hanna Karvonen et al.
CELLS (2019)
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Yuefei Zhu et al.
BIOMOLECULES (2019)
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
Lars Wallstabe et al.
JCI INSIGHT (2019)
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients
Anne-Laure Giraudet et al.
BMC CANCER (2018)
α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10
Huizi Keiko Li et al.
CANCER SCIENCE (2018)
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Michael Y. Choi et al.
CELL STEM CELL (2018)
Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia
Xuejie Jiang et al.
CLINICAL CANCER RESEARCH (2018)
Non-canonical Wnt signaling regulates neural stem cell quiescence during homeostasis and after demyelination
Manideep Chavali et al.
NATURE COMMUNICATIONS (2018)
Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
Philipp Manegold et al.
CANCERS (2018)
A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy
Jiahui Jiang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Human glioblastoma arises from subventricular zone cells with low-level driver mutations
Joo Ho Lee et al.
NATURE (2018)
Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
Fang Fang et al.
Oncotarget (2018)
Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
J. Yu et al.
LEUKEMIA (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
DNA Damage in Stem CellsDNA Damage in Stem Cells
Ilio Vitale et al.
MOLECULAR CELL (2017)
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
Wojciech Szopa et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma
Aman Sharma et al.
FRONTIERS IN ONCOLOGY (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma
David Sarrut et al.
EJNMMI PHYSICS (2017)
WNT signaling in glioblastoma and therapeutic opportunities
Yeri Lee et al.
LABORATORY INVESTIGATION (2016)
WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1
I. Vassallo et al.
ONCOGENE (2016)
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
B. Madan et al.
ONCOGENE (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Targeting autophagy to sensitive glioma to temozolomide treatment
Yuanliang Yan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition
Babita Madan et al.
ONCOTARGET (2016)
Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling
So-Young Hwang et al.
CELL REPORTS (2016)
Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
C. E. Henry et al.
ONCOGENESIS (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
Michael Y. Choi et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity
Shiv K. Singh et al.
EMBO JOURNAL (2015)
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Brenda Auffinger et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups
Yuil Kim et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Phuong N. Le et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Malin Wickstrom et al.
NATURE COMMUNICATIONS (2015)
HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways
Ran Duan et al.
ONCOTARGET (2015)
The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-γ in colitis
Akira Sato et al.
SCIENTIFIC REPORTS (2015)
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Brenda Auffinger et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Targeting aggressive cancer stem cells in glioblastoma
Tracy Seymour et al.
FRONTIERS IN ONCOLOGY (2015)
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Mario L. Suva et al.
CELL (2014)
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Young Hee Choi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
Michael D. Arensman et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Osteoporosis and obesity: Role of Wnt pathway in human and murine models
Graziana Colaianni et al.
WORLD JOURNAL OF ORTHOPEDICS (2014)
Lgr4 Promotes Glioma Cell Proliferation through Activation of Wnt Signaling
Chun-Yong Yu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma
Jun-Xia Zhang et al.
NEURO-ONCOLOGY (2013)
Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures
C. Garcia-Ibarbia et al.
OSTEOPOROSIS INTERNATIONAL (2013)
NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells
Xinxin Tie et al.
PLOS ONE (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma
Esther Rheinbay et al.
CELL REPORTS (2013)
Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition
Ulf D. Kahlert et al.
CANCER LETTERS (2012)
FoxM1 and Wnt/β-Catenin Signaling in Glioma Stem Cells
Aihua Gong et al.
CANCER RESEARCH (2012)
Planar Cell Polarity Links Axes of Spatial Dynamics in Neural-Tube Closure
Tamako Nishimura et al.
CELL (2012)
Wnt/beta-Catenin Signaling in Glioma
Kailiang Zhang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin
Tom N. Grossmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Wnt Proteins
Karl Willert et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
TCF/LEFs and Wnt Signaling in the Nucleus
Ken M. Cadigan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Wnt/Ca2+ signaling pathway: a brief overview
Antara De
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
Dishevelled 2 Signaling Promotes Self-Renewal and Tumorigenicity in Human Gliomas
Teodoro Pulvirenti et al.
CANCER RESEARCH (2011)
Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2
Masayuki Kamino et al.
CANCER SCIENCE (2011)
Calcineurin-NFAT Signaling Critically Regulates Early Lineage Specification in Mouse Embryonic Stem Cells and Embryos
Xiang Li et al.
CELL STEM CELL (2011)
The Wnt/beta-catenin signaling pathway in the adult neurogenesis
Lin Zhang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence
Wanyu L. Lambiv et al.
NEURO-ONCOLOGY (2011)
An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway
Foster C. Gonsalves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
SNAI2/Slug promotes growth and invasion in human gliomas
Hong Wei Yang et al.
BMC CANCER (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells
Kyoung Bin Cho et al.
CANCER LETTERS (2010)
An Updated Overview on Wnt Signaling Pathways A Prelude for More
Tata Purushothama Rao et al.
CIRCULATION RESEARCH (2010)
New insights into the function of Atg9
Jemma L. Webber et al.
FEBS LETTERS (2010)
TWIST1 promotes invasion through mesenchymal change in human glioblastoma
Svetlana A. Mikheeva et al.
MOLECULAR CANCER (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
A gradient of ROR2 protein stability and membrane localization confers brachydactyly type B or Robinow syndrome phenotypes
Wibke Schwarzer et al.
HUMAN MOLECULAR GENETICS (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
β-Catenin hits chromatin: regulation of Wnt target gene activation
Christian Mosimann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations
Cameron Brennan et al.
PLOS ONE (2009)
Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A
Akira Nomachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Wnt-mediated self-renewal of neural stem/progenitor cells
M. Yashar S. Kalani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The soluble Wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo
Venita I. DeAlmeida et al.
CANCER RESEARCH (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line
Nathalie Auger et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Increase in proliferation and differentiation of neural progenitor cells isolated from postnatal and adult mice brain by Wnt-3a and Wnt-5a
Ji Min Yu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Wnt signal pathways and neural stem cell differentiation
Christian Lange et al.
NEURODEGENERATIVE DISEASES (2006)
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in human glioma
C Calatozzolo et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Wnt signaling in the intestinal epithelium: from endoderm to cancer
A Gregorieff et al.
GENES & DEVELOPMENT (2005)
Wnt signalling in stem cells and cancer
T Reya et al.
NATURE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
β-catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system
D Zechner et al.
DEVELOPMENTAL BIOLOGY (2003)
Transcriptional regulators of the human multidrug resistance 1 gene: recent views
S Labialle et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Regulation of cerebral cortical size by control of cell cycle exit in neural precursors
A Chenn et al.
SCIENCE (2002)
Gliomagenesis: Genetic alterations and mouse models
EC Holland
NATURE REVIEWS GENETICS (2001)
Share Paper
